Low oxygen levels in cancer patients arise from a web of overlapping causes, not a single mechanism. The tumor itself can physically block airways, flood the chest cavity with fluid, or spread through the lung’s internal drainage system. Cancer treatments, including chemotherapy, radiation, and immunotherapy, can inflame or scar lung tissue. And systemic problems like anemia, blood clots, infection, and muscle wasting all chip away at the body’s ability to move oxygen from the air into the bloodstream. Understanding which of these drivers is at work matters because each one calls for a different response.
Tumors That Block the Airways
One of the most straightforward ways cancer drops oxygen levels is by physically obstructing air from reaching parts of the lung. When a tumor grows in or near a major airway, it can partially or completely block that passage. The lung tissue downstream collapses, a condition called atelectasis. Patients with lung cancer can develop this collapse after a centrally located tumor plugs a bronchus, and the affected area can range from a small segment to an entire lung.
1Chest Imaging. Lung Cancer: Atelectasis and ConsolidationCollapsed lung tissue no longer participates in gas exchange, so the remaining healthy lung has to compensate. If enough tissue is taken offline, blood oxygen drops. The obstruction can also trap secretions behind the tumor, setting the stage for a secondary infection that further compromises breathing.
A related but less common problem is superior vena cava (SVC) syndrome, where a tumor or enlarged lymph nodes press on the large vein that drains blood from the head and upper body back to the heart. SVC obstruction causes swelling in the face, neck, and arms and can become a medical emergency if it leads to swelling in the brain or around the airway.
2PubMed Central. Superior Vena Cava Syndrome: Etiologies, Manifestations, and TreatmentsFluid Buildup in the Chest
Malignant pleural effusion, where fluid accumulates in the space between the lung and the chest wall, is one of the most common reasons cancer patients become short of breath. Lung cancer and breast cancer are frequent culprits, but almost any cancer that has spread can cause it. The breathlessness is not as simple as the fluid squeezing the lung. Research shows that even after draining a large effusion, the improvement in lung volume often does not match the amount of fluid removed, and changes in measurable breathing parameters can be surprisingly small.
3European Respiratory Society (ERS). Malignant pleural diseaseThis disconnect suggests that the breathlessness involves more than just mechanical compression. Inflammation of the pleural lining, disrupted gas exchange at the lung surface, and diaphragm dysfunction from the weight of the fluid all likely play a role. For patients and caregivers, the practical takeaway is that draining the fluid often helps with comfort, but the degree of relief varies widely from person to person.
Fluid can also collect around the heart. Cancer-related pericardial effusion occurs when tumors invade or spread to the thin sac surrounding the heart, most often from lung cancer, breast cancer, melanoma, or lymphoma. The fluid restricts the heart’s ability to fill and pump, which can reduce the oxygen-rich blood reaching the rest of the body. Some cancer therapies also trigger pericardial effusion, and radiation-related cases may not appear until years after treatment.
4PubMed Central. Pericardial effusion in oncological patients: current knowledge and principles of managementCancer Spreading Through the Lungs’ Lymphatic Network
A less visible but serious cause of low oxygen is pulmonary lymphangitic carcinomatosis, a pattern of cancer spread in which tumor cells infiltrate the lymphatic channels running through the lungs. About 30 to 40 percent of patients with metastatic cancer develop some form of lung involvement, and roughly 6 to 8 percent of those cases involve this lymphatic pattern. The tumor cells clog the lymphatic vessels and trigger thickening of the tissue around the airways and blood vessels, which stiffens the lungs and makes gas exchange progressively harder.
5European Respiratory Review. Pulmonary lymphangitic carcinomatosis presenting as severe interstitial lung disease in a 15-year-old femaleBecause this condition develops diffusely throughout the lungs rather than forming a single visible mass, it can be difficult to diagnose. Patients often present with worsening breathlessness and a dry cough, and imaging may initially be misread as an inflammatory lung disease rather than cancer spread. Oxygen levels can drop steeply once enough of the lymphatic network is compromised.
Blood Clots in the Lungs
Cancer substantially raises the risk of blood clots, and when a clot travels to the lungs it becomes a pulmonary embolism (PE). A PE blocks blood flow through part of the lung, meaning that even though air is reaching the affected area, the blood cannot pick up the oxygen there. The result is a sudden mismatch between ventilation and blood flow that can cause oxygen saturation to plummet.
Research comparing cancer and non-cancer patients with PE found that cancer patients are especially likely to have incidental PEs, clots discovered on scans ordered for other reasons. Active cancer was present in about 71 percent of patients with incidental PE. Among cancer patients with PE, oxygen saturation below 90 percent was associated with roughly 67 percent higher risk of death, highlighting how seriously low oxygen compounds the danger of clots in this population.
6Blood. Clinical Characteristic Outcomes and Mortality Among Cancer and Non-Cancer Patients Presented with Incidental Pulmonary EmbolismAnemia and the Limits of Oxygen Delivery
Even when the lungs are functioning well, the blood needs enough hemoglobin to carry oxygen to the tissues. Cancer frequently causes anemia through bleeding, bone marrow suppression from chemotherapy, chronic inflammation, or the disease itself crowding out normal blood cell production. This anemia is one of the two major drivers of tissue-level oxygen deprivation in cancer, alongside the deficient blood vessel networks that tumors build.
7PubMed Central. Hypoxia Signaling in Cancer: From Basics to Clinical PracticeAnemia also creates a monitoring blind spot. Pulse oximeters estimate oxygen saturation by shining light through the fingertip, and their accuracy degrades as hemoglobin levels fall. Laboratory testing shows that at very low hematocrit levels, pulse oximeter readings can overestimate true oxygen saturation by more than 3 percent, with the error growing worse when actual oxygen levels are already low. The degree of inaccuracy varies between devices, with some consumer-grade models becoming unreliable at higher hematocrit levels than clinical-grade equipment.
8PubMed Central. Quantifying pulse oximeter accuracy during hypoxemia and severe anemia using an in vitro circulation systemFor cancer patients who are already anemic, this means a reassuring-looking number on a fingertip oximeter might mask a real oxygen deficit. If you are monitoring someone at home and they are known to be anemic, keep in mind that the oximeter reading may be rosier than reality, especially during a dip.
When Cancer Treatments Damage the Lungs
The treatments meant to fight cancer can themselves injure the lungs and drive down oxygen levels. This is one of the more frustrating paradoxes in cancer care, and it comes in several forms.
Chemotherapy-Induced Lung Injury
Certain chemotherapy drugs are known to be toxic to lung tissue. Bleomycin, used to treat lymphomas and some germ cell tumors, is perhaps the best-known offender. While effective against the cancer, it can cause severe drug-induced lung injury, including inflammation and scarring that stiffens the lungs and impairs oxygen exchange.
9PubMed Central. Bleomycin-induced lung injury treated with venovenous extracorporeal membrane oxygenation (ECMO) and ultra-protective ventilator settings In severe cases, this can progress to acute lung injury requiring intensive care support.
10PubMed Central. Peroxiredoxin 1 mediates bleomycin-induced acute lung injury in mice via macrophage NOD1/NF-κB axisImmunotherapy Pneumonitis
Immune checkpoint inhibitors have transformed cancer treatment over the past decade, but they occasionally turn the immune system against the lungs. A meta-analysis covering 26 studies found that the overall rate of checkpoint-inhibitor pneumonitis was about 2.7 percent across all severity grades, with roughly 0.8 percent of patients developing severe cases. The most common symptoms are shortness of breath, cough, and fever. Most cases are mild to moderate, but a small fraction, around 0.2 percent, prove fatal.
11PubMed Central. Pneumonitis Induced by Immune Checkpoint Inhibitors: From Clinical Data to Translational InvestigationRadiation-Induced Lung Disease
Radiation therapy aimed at chest tumors inevitably exposes some surrounding healthy lung tissue. The resulting injury unfolds in two phases: an early inflammatory phase known as radiation pneumonitis, followed by a later scarring phase that can harden into permanent fibrosis. Both phases can compromise oxygen levels, with pneumonitis causing acute drops and fibrosis reducing long-term lung capacity.
12PubMed Central. Radiation-Induced Lung Injury-Current Perspectives and ManagementSurgical Complications
When part of a lung is removed to treat cancer, the remaining lung usually compensates over time, but complications can arise. One serious possibility is a bronchopleural fistula, an abnormal connection between an airway stump and the space around the lung. In a surgical series of 39 fistula repairs, the overall success rate was 59 percent and the mortality rate was over 56 percent, reflecting how dangerous this complication can be.
13Wiley Online Library. Postoperative bronchopleural fistula repair: Surgical outcomes and adverse factors for its successInfections in Weakened Lungs
Cancer patients face an elevated risk of pneumonia for a long list of reasons. Chemotherapy can suppress white blood cell counts, leaving the immune system unable to fight off bacteria and fungi. Tumors can distort the architecture of the airways, trapping secretions that become breeding grounds for infection. Swallowing difficulties, common in head and neck cancers or in patients debilitated by treatment, raise the risk of aspiration pneumonia. And for patients who have undergone stem cell transplants, graft-versus-host disease adds another layer of immune vulnerability.
14PubMed Central. Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and ManagementPneumonia in a cancer patient is often harder to treat and more likely to become life-threatening than in someone with a healthy immune system. The combination of an already-compromised lung, a weakened immune response, and limited reserve from other cancer-related problems means infections can spiral quickly.
Muscle Wasting and Breathing Power
Advanced cancer often triggers cachexia, a wasting syndrome that strips away muscle mass even when patients are eating. If this muscle loss affects the diaphragm, the main muscle responsible for breathing, it can directly weaken the body’s ability to ventilate. Animal research has shown that cancer cachexia causes significant atrophy in all diaphragm muscle fiber types, with measurable drops in the force the diaphragm can generate and clear impairment of ventilation.
15PubMed Central. Diaphragm and ventilatory dysfunction during cancer cachexiaIn human patients, this translates to progressive breathlessness that worsens as the disease advances, even if the lungs themselves are structurally intact. Cachexia is notoriously difficult to reverse with nutrition alone, making respiratory muscle weakness one of the more challenging contributors to low oxygen in late-stage disease.
More rarely, certain cancers produce hormones or hormone-like substances that throw the body’s chemistry off balance. A case report described a patient with small-cell lung cancer who presented with severe breathlessness caused by ectopic production of a stress hormone (ACTH), leading to profound metabolic derangement, fluid retention, and respiratory failure, all before the cancer itself was diagnosed.
16PubMed Central. Cardio-respiratory failure secondary to ectopic Cushing’s syndrome as the index presentation of small-cell lung cancerWhen Supplemental Oxygen Does Not Help as Expected
A common assumption is that if a cancer patient feels breathless, giving them supplemental oxygen will help. The reality is more complicated, and the evidence here has surprised many clinicians. A randomized trial in patients with life-limiting illness and refractory breathlessness found that oxygen delivered by nasal cannula provided no better relief than room air blown through the same device. Breathlessness scores improved slightly in both groups over six days, but there was no meaningful difference between oxygen and plain air.
17PubMed Central. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trialA separate trial focused on cancer patients with breathlessness during exercise reached a similar conclusion: no significant differences in breathlessness, fatigue, or walking distance between supplemental oxygen and air.
18PubMed. A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspneaThis does not mean oxygen is useless in cancer care. For patients whose blood oxygen is genuinely low, measured and confirmed, supplemental oxygen is a standard and recommended intervention. The American Society of Clinical Oncology’s guidelines on managing cancer-related breathlessness recommend standard supplemental oxygen for patients with documented hypoxemia, alongside nonpharmacologic strategies like directing a fan at the face.
19PubMed. Management of Dyspnea in Advanced Cancer: ASCO GuidelineThe distinction is between breathlessness with low oxygen and breathlessness without low oxygen. Many cancer patients feel starved for air even when their blood oxygen is normal, driven by inflammation, anxiety, diaphragm weakness, or altered breathing signals from the brain. For those patients, strapping on an oxygen mask may be more burdensome than helpful, and simpler measures like a handheld fan or breathing techniques can be equally effective. If you are caring for someone with cancer who feels breathless, measuring their oxygen level with a pulse oximeter (keeping in mind the anemia caveat) is a reasonable first step before assuming supplemental oxygen is the answer.